Although mainly considered as a tumorigenic protein, partly because some of its targets are cell cycle‐ and apoptosis‐regulating proteins and partly because its expression pattern increases in some malignancies 16, HuR involvement in cancer is likely highly complex 17 according to the available in vivo experimental data 18, 19. Here, ELAVL1 is linked to cancer.